Prognostic value of ctDNA-derived maximum somatic allele frequency in patients with metastatic gastric cancer
Background: Metastatic gastric cancer (GC) is biologically heterogeneous; however, current staging classifies all metastatic cases as stage IV without reflecting this variability. Circulating tumor DNA (ctDNA)-derived biomarkers, including maximum somatic allele frequency (MSAF), may serve as surrog...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publishing
2026-01-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Acceso en liña: | https://doi.org/10.1177/17588359251414103 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|